![](/img/cover-not-exists.png)
Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma
Bensimon, Arielle G., Zhong, Yichen, Swami, Umang, Briggs, Allison, Young, Joshua, Feng, Yuan, Song, Yan, Signorovitch, James, Adejoro, Oluwakayode, Chakravarty, Abhiroop, Chen, Mei, Perini, Rodolfo FJournal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2020.1799771
Date:
July, 2020
File:
PDF, 1.30 MB
2020